These findings were confirmed by meta-analysis, which reported a Standard Mortality Rate (SMR) close to that of the general population in biochemically controlled acromegaly patients (random serum GH <2.5 μg/L, or normalization of IGF-1 levels at the last follow-up) (26). Here, IGF1 is linked to acromegaly.